Chronic hepatitis C: Interferon retreatment of relapsers. A meta- analysis of individual patient data

Hepatology

Volumn 30, Issue 3, 1999, Pages 801-807

  Camma, Calogero ^a,i   Giunta, Marco ^b   Chemello, Liliana ^c   Alberti, Alfredo ^c   Toyoda, Hidenori ^d   Trepo, Christian ^e   Marcellin, Patrick ^f   Zahm, Friederike ^g   Schalm, Solko ^h   Craxì, Antonio ^b  

^a CNR   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d OGAKI MUNICIPAL HOSPITAL   (Japan)

^e HÔTEL DIEU   (France)

^f BEAUJON HOSPITAL   (France)

^g F HOFFMANN LA ROCHE LTD   (Switzerland)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ Clinica Medica I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RELAPSE; RETREATMENT;

ADULT; AGED; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MIDDLE AGED; RECURRENCE; RNA, VIRAL;

EID: 0032820291     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300329     Document Type: Article

References (26)

1. Cammà C, Giunta M, Pinzello GB, Morabito A, Verderio P, Pagliaro L. Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol 1999;94:581-595.
2. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, et al., for the International Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493-1499.
3. Chow WC, Boyer N, Pouteau M, Castelnau C, Martinot-Peignoux M, Martins-Amado V, Degos F, et al. Re-treatment with interferon alfa of patients with chronic hepatitis C. HEPATOLOGY 1998;27:1144-1148.
4. Chemello L, Cavalletto L, Donada C, Bonetti P, Casarin P, Urban F, Bernardinello E, et al. Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C. Gastroenterology 1997;113:1654-1659.
5. Heathcote EJL, Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, Albert DG, et al., and the Consensus Interferon Study Group. Retreatment of chronic hepatitis C with consensus interferon. HEPATOLOGY 1998;27:1136-1143.
6. Almasio PL, Di Marco V, Bonura C, Fuschi P, Cammà C, Lo lacono O, Artini M, et al. Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon. Dig Dis Sci 1999;44:1013-1019.
7. Picciotto A, Brizzolara R, Campo N, Poggi G, Sinelli N, DeConca V, Giudici-Cipriani A. Two year interferon retreatment may induce a sustained response in relapsing patients with chronic hepatitis C [Abstact]. HEPATOLOGY 1996;24(Suppl):273A.
8. Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, et al., and le Groupe detude et de traitement du virus de lhepatitie C. Better efficacy of a 12-months interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-months treatment: a multicenter, controlled, randomized trial. HEPATOLOGY 1998;28:1680-1686.
9. Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osama T, Kiriyama S. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994;89:1453-1457.
10. Weiland O, Zhang YY, Widell A. Serum HCV-RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. Scand J Infect Dis 1993;25:25-30.
11. Pardo M, Coronal T, Herrero M, Marriott E, Artillo S, Quiroga JA, Carren̄o V. Retreatment of chronic hepatitis C virus infection. Lancet 1994;343:1568-1569.
12. Horiike N, Kurose K, Ohkura I, Masumoto T, Nakanishi K, Michitaka K, Onji M. Retreatment with interferon in chronic hepatitis C [Abstract]. J Hepatol 1994;21:1155.
13. Iaquinto G, Ambrosone L, De Vita A, Masucci F, Rambaldi M. Response to retreatment with alfa interferon in relapsed and non responder patients [Abstract]. J Hepatol 1995;23(Suppl):194.
14. Bonkowsky HL, Clifford BD, Smith LJ, Allan C, Banner B. High-dose interferon-alpha-2b for retreatment of non-responders or relapsing patients with chronic hepatitis C: a controlled randomized trial. Dig Dis Sci 1996;41:149-154.
15. Le X, Zhou X, Dai X. Evaluation of interferon alpha for the treatment of relapsed hepatitis C [Abstract]. HEPATOLOGY 1996;24(Suppl):536A.
16. Gerken G, Teuber G, Goergen B, Meyer zum Buschenfelde KH. Interferonalpha retreatment in chronic hepatitis C. J Hepatol 1995;22(Suppl):118-121.
17. Kakumu S, Yoshioka K. Retreatment with interferon in patients with chronic hepatitis C [letter]. J Hepatol 1994;21:483.
18. Marriott E, Quiroga JA, Carreno V Retreatment of chronic hepatitis C with interferon-α. J Infect Dis 1992:166:1200-1201.
19. Bresci G, Parisi G, Banti S, Capzia A. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-α. J Viral Hepat 1995;2:155-158.
20. d'Aquino M, Tempesta D, Bibiani S, Vianello G, Pipan C, Bellati G, Colloredo G. Chronic hepatitis C: an analysis of factors which influence the responce to interferon therapy proven to be useful to optimize a second course [Abstract]. HEPATOLOGY 1996;24(Suppl):498A.
21. Hagiwara H, Hayashi N, Oshita M, Katayama K, Kasahara A, Fusamoto H, Kamada T. Retreatment with 24-week course of interferon-alpha for patients with chronic hepatitis C. Int Hepatol Commun 1996;5:135-142.
22. Alberti A, Chemello L, Noventa F, Cavalletto L, De Salvo GL. Therapy of hepatitis C: re-treatment with alpha interferon. HEPATOLOGY 1997; 26(Suppl):137S-142S.
23. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1203.
24. Lindsay KL. Therapy of chronic hepatitis C: overview. HEPATOLOGY 1997;26(Suppl):71S-77S.
25. Pagliaro L, Craxi A, Cammá C, Tinè F, Di Marco V, Lo lacono O, Almasio P. Interferon-α for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. HEPATOLOGY 1994;19:820-828.
26. SAS Technical Report. SAS/STAT Software: Changes & Enhancements, Release 6.07. Cary, NC: SAS Institute Inc. 1992.